Products & Services
Markets
Contact Us
Become a Partner
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Reach out to us on
0120-4918900
Or
Get a call back
Click here
Markets
Company Info
Equity
IPO
Company Info
Derivatives
News
Announcements
Mutual Fund
Insurance
Share Price
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
CORPORATE NEWS
You can view News of the company.
Lupin Ltd.
GO
Aug 24, 04:01
BSE
2190.00
( -3.00 -0.14%)
Volume
12257
Prev. Close
2193.00
Open Price
2224.50
Today's Low / High
2181.00
2224.50
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
1881.80
2530.00
Aug 24, 03:59
NSE
2188.00
( -13.80 -0.63%)
Volume
475169
Prev. Close
2201.80
Open Price
2199.80
Today's Low / High
2180.30
2199.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2188.00 (119)
52 Wk Low / High
1875.00
2529.50
ISIN No
INE326A01037
Market Cap. (
in Cr. )
100042.99
P/BV
4.19
Book Value (
)
521.95
BSE Code
500257
52 Week High/Low (
)
2530/1875
FV/ML
2/1
P/E(X)
18.76
NSE Code
LUPINEQ
Book Closure
17/07/2026
EPS (
)
116.63
Div Yield (%)
0.82
Date and Time
Headlines
21-Aug-2026 8:20PM
Lupin Q1 net profit up 27.56% at Rs 2714.60 cr
20-Aug-2026 12:56PM
Lupin, Tenpoint Therapeutics enter into partnership to commercialise YUVEZZI
20-Aug-2026 10:55AM
Lupin - Exclusive License Agreement With Visus Therapeutics, Inc. U.S.A.
20-Aug-2026 10:47AM
Lupin - Arrangements for strategic, technical, manufacturing, or marketing tie up
18-Aug-2026 10:11PM
Lupin - Announcement under Regulation 30 (LODR)-Demise
18-Aug-2026 10:05PM
Lupin - Demise
17-Aug-2026 5:58PM
Lupin gets USFDA approval for Generic Drug to treat excessive daytime sleepiness
17-Aug-2026 12:21PM
Lupin - Announcement under Regulation 30 (LODR)-Press Release / Media Release
17-Aug-2026 12:19PM
Lupin - Press Release
12-Aug-2026 5:48PM
Lupin - Analysts/Institutional Investor Meet/Con. Call Updates